Can baseline C-reactive protein level predict functional outcome in acute ischaemic stroke? A meta-analysis

References

• Begg, C.B. and Mazumdar, M., 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics, 50 (4), 1088–1101.
   PubMed Web of Science ®Google Scholar
• Bunevicius, A., et al., 2014. Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study. Endocrine, 45 (2), 213–220.
   PubMed Web of Science ®Google Scholar
• Chamorro, A., 2004. Role of inflammation in stroke and atherothrombosis. Cerebrovascular diseases (Basel, Switzerland), 17 (Suppl. 3), 1–5.
   Google Scholar
• Di Napoli, M., et al., 2005. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke, 36 (6), 1316–1329.
   PubMed Web of Science ®Google Scholar
• Egger, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ (clinical research ed.), 315 (7109), 629–634.
   PubMed Web of Science ®Google Scholar
• Feigin, V.L., Norrving, B., and Mensah, G.A., 2017. Global burden of stroke. Circulation research, 120 (3), 439–448.
   PubMed Web of Science ®Google Scholar
• Geng, H.H., et al., 2016. The relationship between C-reactive protein level and discharge outcome in patients with acute ischemic stroke. International journal of environmental research and public health, 13 (7), 636.
   Web of Science ®Google Scholar
• Gong, X., et al., 2013. Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis. Mediators of inflammation, 2013, 1–7.
   Web of Science ®Google Scholar
• Haeusler, K.G., et al., 2015. Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke—a retrospective analysis. BMC neurology, 15, 164.
   PubMed Web of Science ®Google Scholar
• Hertog, H.M., et al., 2009. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. Journal of neurology, 256 (12), 2003–2008.
   PubMed Web of Science ®Google Scholar
• Hou, D., et al., 2017. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion. Neurological research, 39 (11), 981–987.
   PubMed Web of Science ®Google Scholar
• Huţanu, A., et al., 2018. Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-dimers, NGAL and NSE measured using a biochip array. Acta pharmacologica sinica, 39 (7), 1228–1236.
   PubMed Web of Science ®Google Scholar
• Irimie, C.A., et al., 2018. C-reactive protein and T3: new prognostic factors in acute ischemic stroke. Journal of stroke and cerebrovascular diseases, 27 (10), 2731–2737.
   PubMed Web of Science ®Google Scholar
• Karlinski, M., et al., 2014. Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis. Acta neurologica scandinavica, 130 (5), 305–311.
   PubMed Web of Science ®Google Scholar
• Li, J. and Fine, J.P., 2011. Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis. Biostatistics (Oxford, England), 12 (4), 710–722.
   PubMed Web of Science ®Google Scholar
• Libby, P., 2002. Inflammation in atherosclerosis. Nature, 420 (6917), 868–874.
   PubMed Web of Science ®Google Scholar
• Liberati, A., et al., 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology, 62 (10), e1.
   PubMed Web of Science ®Google Scholar
• Matsuo, R., et al., 2016. Plasma C-reactive protein and clinical outcomes after acute ischemic stroke: a prospective observational study. PLoS one, 11 (6), e0156790.
   PubMed Web of Science ®Google Scholar
• Ng, G.J.L., et al., 2017. Stroke biomarkers in clinical practice: a critical appraisal. Neurochemistry international, 107, 11–22.
   PubMed Web of Science ®Google Scholar
• Qu, X., et al., 2018. Prognostic value of white blood cell counts and C-reactive protein in acute ischemic stroke patients after intravenous thrombolysis. Current neurovascular research, 15 (1), 10–17.
   PubMed Web of Science ®Google Scholar
• Rocco, A., et al., 2015. Follow-up C-reactive protein level is more strongly associated with outcome in stroke patients than admission levels. Neurological sciences, 36 (12), 2235–2241.
   PubMed Web of Science ®Google Scholar
• Shiber, J.R., Fontane, E., and Adewale, A., 2010. Stroke registry: hemorrhagic vs ischemic strokes. The American journal of emergency medicine, 28 (3), 331–333.
   PubMed Web of Science ®Google Scholar
• Sienkiewicz-Jarosz, H., et al., 2009. Predictive value of selected biochemical markers of brain damage for functional outcome in ischaemic stroke patients. Neurologia i neurochirurgia polska, 43 (2), 126–133.
   PubMed Web of Science ®Google Scholar
• Tsai, N.W., et al., 2012. The association of statin therapy and high-sensitivity C-reactive protein level for predicting clinical outcome in acute non-cardioembolic ischemic stroke. Clinica chimica acta, 413 (23–24), 1861–1865.
   PubMed Web of Science ®Google Scholar
• Tsukagawa, T., et al., 2017. Elevated serum high-mobility group box-1 protein level is associated with poor functional outcome in ischemic stroke. Journal of stroke and cerebrovascular diseases, 26 (10), 2404–2411.
   PubMed Web of Science ®Google Scholar
• Tu, W.J., et al., 2013. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurological research, 35 (9), 912–921.
   PubMed Web of Science ®Google Scholar
• Wang, C., et al., 2016. Procalcitonin is a stronger predictor of long-term functional outcome and mortality than high-sensitivity C-reactive protein in patients with ischemic stroke. Molecular neurobiology, 53 (3), 1509–1517.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2020. C-reactive protein, infection, and outcome after acute ischemic stroke: a registry and systematic review. Current neurovascular research, 16 (5), 405–415.
   Web of Science ®Google Scholar
• Wells G, et al., 2020. The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [Accessed 19 June 2020].
   Google Scholar
• Welsh, P., et al., 2009. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovascular diseases, 27 (3), 247–253.
   PubMed Web of Science ®Google Scholar
• Whiteley, W., et al., 2009. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke, 40 (5), e380–e389.
   PubMed Web of Science ®Google Scholar
• Youn, C.S., et al., 2012. Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. American journal of emergency medicine, 30 (1), 124–128.
   PubMed Web of Science ®Google Scholar
• Yu, B., et al., 2019. C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis. Bioscience reports, 39 (2), 28.
   Google Scholar